Previous Article | Next Article 
Infection and Immunity, June 2001, p. 3703-3712, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3703-3712.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Intrachromosomal Recombination within the
vsp Locus of Mycoplasma bovis Generates a
Chimeric Variable Surface Lipoprotein Antigen
Inessa
Lysnyansky,1
Yael
Ron,1
Konrad
Sachse,2 and
David
Yogev1,*
Department of Membrane and Ultrastructure
Research, The Hebrew University-Hadassah Medical School, Jerusalem
91120, Israel,1 and Federal Institute
for Health Protection of Consumers and Veterinary Medicine,
Division 4, Jena, Germany2
Received 2 November 2000/Returned for modification 29 January
2001/Accepted 7 March 2001
 |
ABSTRACT |
A family of 13 related but divergent vsp genes was
recently found in the chromosome of the bovine pathogen
Mycoplasma bovis. The vsp genomic locus was
shown to undergo high-frequency rearrangements and to mediate
phenotypic switching of variable lipoprotein antigens (Vsps) on the
mycoplasma cell surface. Here we report that the vsp gene
repertoire is subject to changes. Genetic analysis of M. bovis clonal isolates displaying distinct Vsp phenotypes showed that an intergenic recombination event between two closely related members of the vsp gene family, the formerly expressed
vspA gene and the vspO gene, led to the
formation of a new chimeric and functional vsp gene,
vspC. The 5' end of the recombination event was identified
within the highly conserved vsp-upstream region, while the
3' end was localized within the first repetitive domain (RA1) present in both vspA and vspO
structural genes. As a result, the vspC gene is an
embodiment of the following domains: an N-terminus-encoding region
linked to the highly conserved vsp-upstream region provided by the vspO gene; and a C-terminus-encoding region and the
more distal and divergent vsp-upstream region acquired from
the vspA gene. The generation of chimeric genes encoding
surface antigens may provide an important element of genetic variation
and an additional source of antigenic diversification within the
mycoplasma population.
 |
INTRODUCTION |
One of the most effective strategies
used by bacterial pathogens to avoid host immune recognition is the
ability to rapidly change their surface antigenic repertoire and vary
their immunogenicity (22, 25, 30). A common theme for
generating and maintaining population diversity is the utilization of
genetic systems consisting of multiple related variable genes organized
as a gene family. Oscillation at high frequency of each individual gene
between on and off expression states (phase variation), in conjunction with the ability of each gene to produce distinct size variants (size
variation), allow the generation of numerous combinations of antigenic
phenotypes even in a small, clonal population of bacteria, such as the
limiting inoculum that initiates an infection (23, 25,
30).
Mycoplasmas represent the smallest self-replicating life forms on earth
and phylogenetically are related to gram-positive eubacteria
(23). Their remarkably small genomes, the lack of a rigid
cell wall, and the absence of many enzymatic pathways generate an image
of impotent microorganisms. However, many mycoplasma species are
recognized as the etiological agents of human and animal diseases,
causing in many cases acute and chronic infections with a wide range of
complications (31). The successful persistence of
pathogenic mycoplasmas within their host environments and their ability
to evade the host immune system for a long period of time have been
attributed in part to the fact that the mycoplasmas, like other
well-established bacterial pathogens, possess a remarkable capability
for rapid diversification of their cell surface antigens (23,
37). In most cases, surface antigenic variation in the mycoplasmas is achieved by multigene families encoding surface lipoproteins, as has been shown for Mycoplasma hyorhinis
(38), Mycoplasma pulmonis (5),
Mycoplasma synoviae (17), Mycoplasma gallisepticum (2), and Mycoplasma bovis
(14).
M. bovis, a bovine pathogen that causes mastitis, pneumonia,
and arthritis in cows and calves (10, 20), expresses
several highly immunogenic and abundant variable surface lipoprotein
antigens designated Vsps. The three members of this family identified
so far (VspA, VspB, and VspC) (3) have been shown to
possess the following features: (i) independent high-frequency phase
variation, (ii) independent high-frequency size variation, (iii)
membrane anchorage via an N-terminal domain and a surface-exposed
C-terminal region, (iv) extensive repetitive domains extending from the
N terminus to the C terminus, and (v) regions of shared epitopes. These
three Vsps were identified as distinct translational products based on
their monoclonal antibody (MAb) and polyclonal antibody epitope
profiles and on their characteristic structural fingerprint patterns of
degradation at carboxypeptidase Y cleavage sites (3).
Notably, although VspA, VspB, and VspC were shown to be three distinct
translational products expressed on the mycoplasma cell surface,
coexpression of VspA and VspC in a single clonal isolate was not
observed. The extensive Vsp phenotypic switching in M. bovis
was also shown to be associated with high-frequency chromosomal
rearrangements occurring within the vsp genomic locus (13). Recently, the vsp genomic locus from an
M. bovis clonal isolate coexpressing the VspA and the VspB
lipoproteins was identified and characterized (14). A
cluster of 13 related but divergent single-copy vsp genes
comprising the vsp locus was identified. Interestingly,
however, sequence analysis as well as Southern blot hybridiztions of
genomic DNA failed to detect the vspC gene within the
vsp locus or elsewhere on the chromosome of the M. bovis clonal isolate expressing the VspA lipoprotein.
The aim of this study was to identify and characterize the
vspC gene in clonal isolates expressing this product and
discern the meaning of its absence in clonal isolates expressing VspA. This report provides evidence that the vsp genomic
repertoire of M. bovis is subject to changes. We show that
an intergenic recombination event occurring at a high frequency between
two members of the vsp gene family, vspA and
vspO, results in the generation of a new and chimeric
vsp gene, vspC.
 |
MATERIALS AND METHODS |
Bacterial strains, vectors, and plasmids.
Clonal isolates of
M. bovis type strain PG45 expressing a 63-kDa product of
VspA (clone 7) and 75- and 79-kDa products of VspC (clones 168 and 166, respectively) have been described elsewhere (3, 13).
Clonal isolate 182, expressing a 75-kDa VspC product, was isolate and
purified as previously described (3). The geographic origin and site of isolation of M. bovis PG45 were
previously described (3). All clonal isolates were
propagated at 37°C in a modified standard mycoplasma broth medium as
previously described (3). The Escherichia coli
strain used was DH5
MCR (Gibco BRL Life Technologies, Inc.,
Gaithersburg, Md.). Recombinant clones were constructed in the plasmid
vector pBluescript II KS(+) (Stratagene, La Jolla, Calif.). Recombinant
plasmid pKO35, carrying the vspO gene, was
constructed by cloning the PCR-amplified vspO gene from M. bovis PG45 clonal isolate 7 into the plasmid vector pBS.
Two oligonucleotides, 5'-CTGCTTAGTTGAGTGTTGTTCC-3' and
5'-CCTGGGTAACAGATGCAA-3', containing HindIII
restriction sites at their ends, were used for PCR amplification and
cloning of the vspO gene (14). Expression of
M. bovis vspC and vspO genes in E. coli was performed by the T7 polymerase-promoter system of Tabor
and Richardson (33) as previously described
(13). E. coli strain DH5
MCR (pGP1-2) was used as a host for expression of mycoplasma proteins under T7 promoter control.
Chemicals, media, and growth conditions.
E. coli
cultures for plasmid isolation were grown with shaking at 37°C in
Luria-Bertani broth (28). E. coli cultures for expression of mycoplasma proteins under T7 promoter control
(33) were grown at 30°C with shaking in M9 medium
(28) supplemented with a mixture of all amino acids.
Restriction enzymes, T4 ligase, and T4 polynucleotide kinase were
purchased from MBI Fermentas (Amherst, N.Y.) and used according to the
recommendations of the manufacturer.
5-Bromo-4-chloro-3-indolyl-
-D-galactoside (X-Gal), ampicillin, kanamycin, and rifampin were purchased from Sigma Chemicals, St. Louis, Mo. [
-32P]ATP and
[
-32P]CTP were purchased from Amersham, Little
Chalfont, United Kingdom.
SDS-PAGE and Western immunoblotting.
Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed by
the method of Laemmli (12). Samples were prepared by
heating at 100°C for 5 min in sample buffer (2% SDS, 5% [vol/vol]
2-mercaptoethanol, 10% [vol/vol] glycerol, 62.5 mM Tris [pH 6.8]).
Proteins were separated in 9% acrylamide gels and transferred to
nitrocellulose membrane filters (0.45-µm pore size; Schleicher & Schuell, Dassel, Germany) by the method of Towbin et al.
(35). Blots were incubated for 1 h at room
temperature with phosphate-buffered saline containing 3% bovine serum
albumin (Sigma) and then incubated overnight at 4°C with the primary
antibodies diluted in phosphate-buffered saline (PBS) containing 20%
(vol/vol) fetal calf serum. After three washes in PBS buffer, blots
were incubated for at least 2 h at room temperature in
peroxidase-conjugated goat antiserum to mouse immunoglobulin M or to
mouse immunoglobulin G (Jackson ImmunoResearch Laboratories, West
Grove, Pa.; Nordic, Tilburg, The Netherlands). For detection, enzyme
substrates 4-chloro-1-naphthol (Aldrich, Steinheim, Germany) and
o-dianisidine (Sigma) were used.
DNA preparation and manipulation.
Genomic DNAs from type
strain M. bovis PG45 and from M. bovis clonal
isolates were extracted and purified by the method of Marmur
(15). Plasmid isolation, restriction endonuclease
digestions, and gel electrophoresis of DNA and proteins were performed
as previously described (3, 13, 14).
Oligonucleotides; labeling and hybridization conditions.
vsp sequence-specific oligonucleotides were synthesized at
the interdepartmental facility of the Hebrew University-Hadassah Medical School on a model 380B DNA synthesizer (Applied Biosystems, Inc., Foster City, Calif.). A sequence 18 nucleotides (nt) long, 5'-GGACAAGGCACATCAGCT-3', was designated ro-2; a sequence 35 nt long, 5'-GCTTTTATTTAGTTCTTAATACTTCATATAATAAA-3', was
designated cas-2; a sequence 20 nt long,
5'-GCCTTGATCTGTATTTTCGC-3', was designated nt-2; and a
sequence 20 nt long, 5'-GTTAGTTCCTGCACCTTGTT-3', was
designated ra-4. The conditions for oligonucleotide labeling and
hybridization as well as for DNA hybridization have been described elsewhere (13, 14).
Cloning of the vsp locus from VspA and VspC clonal
isolates.
Genomic libraries were constructed with the
bacteriophage FIX II/Xho I vector (Stratagene) with
partially digested Sau3A chromosomal fragments from M. bovis PG45 clonal isolate 7, expressing a 63-kDa product of VspA,
or from M. bovis PG45 clonal isolate 168, expressing a
75-kDa product of VspC (Fig. 1A, lanes 1 and 2, respectively). Agar plates containing approximately 2 × 103 PFU were overlaid for 10 min with nitrocellulose
filters (0.45-µm pore size; Schleicher & Schuell, Dassel, Germany).
Plaques were screened by colony blot hybridization with
32P-labeled recombinant plasmid pKA63 carrying
the vspA gene (13) as a probe for the VspA
isolate or with recombinant plasmid pKCl75 carrying the
vspC gene (see Results) as a probe for the VspC isolate. The
conditions for DNA labeling and hybridization have been described elsewhere (13, 14). Positive phages were picked, replated at low density, and rescreened. After three rounds of plaque
purification, positive phages were isolated for further analysis.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Western blot analysis of two M. bovis
clonal isolates expressing the VspA (lane 1, clone 7) and VspC (lane 2, clone 168) products. Whole organisms were subjected to SDS-PAGE and
immunoblotted with MAb 1E5 (2). The VspA63 and
VspC75 products are indicated. (B) Identification of the
M. bovis vspC gene. Four-microgram aliquots of chromosomal
DNAs of the isolates were digested with HindIII,
subjected to Southern blot hybridization, and probed with the
-32P-labeled ra-4 oligonucleotide.
HindIII genomic fragments carrying the vspB,
vspK, and vspL genes or the vspA gene are
indicated by labeled arrows (14). Molecular size markers
are shown on the right. An open arrow marks a 1.5-kb
HindIII genomic fragment present in the VspC variant.
(C) Expression in E. coli of the recombinant vspC
gene. E. coli cells expressing under selective induction of
the T7 promoter control the recombinant plasmid pKC75
carrying the vspC gene were separated by SDS-PAGE and
immunoblotted with MAb 1E5 (lane 1). Total mycoplasma proteins of the
M. bovis VspC clonal isolate (A, lane 2) were used as a
positive control (lane 2). The recombinant VspC product expressed in
E. coli as well as the authentic VspC product expressed in
the mycoplasma are indicated by arrows.
|
|
PCR.
PCRs were carried out in 100-µl volumes containing 10 ng of template DNA, 4 U of ExSel DNA polymerase in 1× S-T Exsel buffer (MBI Fermentas), 2 mM MgSO4, 2 mM mix of deoxynucleoside
triphosphates, and 500 ng of each primer. PCR amplifications were
performed using a PC-Personal cycler (Biometra, Gottingen, Germany)
programmed for 31 cycles. For amplifying the 2.1-kb genomic fragment,
primers 5'-TGTGGTCAAACCTATGGTTAG-3' and
5'-GCTTGTTCTCTTTGACCCAC-3' (designated Pk-1 and P5-1,
respectively [see Fig. 3B]) were used with the following cycling
conditions: an initial cycle of 3-min denaturation at 95°C, 90 s
of annealing at 54°C, and 150 s of polymerase extension at
72°C, followed by 30 cycles of 30 s at 95°C, 45 s at
54°C, and 2 min at 72°C. For amplifying the 1.5-kb genomic
fragment, primers P5-1 and nt-2 (see Fig. 3A) were used with the
following cycling conditions: initial denaturation for 3 min at 95°C,
90 s of annealing at 58°C, and 2 min of polymerase extension at
72°C, followed by 30 cycles of 30 s at 95°C, 30 s at 58°C,
and 90 s at 72°C. The reaction mixtures were then incubated for
a 10-min extension step at 72°C and allowed to cool slowly at 4°C.
The resultant PCR products were purified by High Pure filter columns (Boehringer Mannheim GmbH, Indianapolis, Ind.) and directly sequenced.
DNA sequence analysis.
DNA sequence analysis of both strands
was performed by the dideoxy-chain termination method
(29). The T7 promoter sequence and the T3 sequence located
on the pKS vector, as well as vsp-related sequences, were
used as primers. Sequencing was done using a model ABI PRISMA 377 automatic sequencer dye-terminator cycle sequencer (Perkin-Elmer,
Foster City, Calif.). Sequence data were analyzed using the computer
software AssemblyLIGN and MacVector 6.0.
Nucleotide sequence accession number.
The nucleotide
sequence of the vspC gene has been assigned GenBank
accession number AF224060.
 |
RESULTS |
Identification, genomic localization, and characterization of the
vspC gene in a clonal isolate of M. bovis.
Genetic analysis of an M. bovis PG45 clonal isolate
coexpressing the VspA and VspB lipoproteins revealed that the
vspC gene was absent in this isolate (14).
However, other M. bovis clonal isolates, expressing distinct
VspC products, were clearly identified and characterized (3,
13).
To address this issue, two clonal isolates of M. bovis type
strain PG45, one expressing the VspC product (Fig. 1A, lane 2) and the
second expressing the VspA product (Fig. 1A, lane 1), were chosen for
further analysis. Restricted genomic DNAs from these isolates were
subjected to Southern blot hybridization (Fig. 1B) with the ra-4
oligonucleotide as a probe (13). The ra-4 oligonucleotide
was chosen as the preferred probe for the identification of the
vspC gene, as earlier studies have shown that the VspA and
the VspC products exhibit remarkably similar polypeptide structures and
regions of shared epitopes (3, 27). The high structural similarity was most profound near the C-terminal end, a region consisting of identical repetitive coding sequences. This repetitive domain, designated RA4, represents a significant portion of
the vspA gene and was shown by Southern blot analysis to be
localized in two distinct HindIII genomic fragments: a
1.45-kb HindIII carrying the vspA gene; and a
3.2-kb fragment carrying the vspB, vspK, and vspL
genes (Fig. 1B, lane 1) (14). Interestingly, in addition to the 3.2-kb fragment that was observed in both isolates, the VspC
isolate possesses an HindIII fragment which is slightly
larger than the vspA-bearing fragment in the isolate
expressing the VspA product (Fig. 1B, lane 2 and lane 1, respectively).
No other strongly hybridizing fragments that might carry the
vspC gene were detected in the VspC variant (Fig. 1B). These
findings, along with our earlier observations indicating that
VspA63 and VspC75 are structurally remarkably
similar (3), led us to focus on the 1.5-kb
HindIII fragment of the VspC variant for further study.
The 1.5-kb HindIII fragment was excised from the gel and
subcloned into the plasmid vector pKS. Each orientation of this 1.5-kb fragment was cloned separately relative to the T7 promoter located on
pKS, generating the recombinant plasmids pKCl75 and
pKC275. Both recombinant plasmids were expressed in
E. coli using the T7 RNA polymerase promoter system
(33). A polypeptide band of 75 kDa was synthesized in
E. coli by the recombinant pKCl75 clone (Fig.
1C, lane 1). The size of the expressed protein in E. coli was similar to that of the authentic VspC protein expressed in the
mycoplasma (Fig. 1C, lane 2), indicating that the 1.5-kb
HindIII genomic fragment contained the complete
vspC gene.
The nucleotide sequence of the 1.5-kb HindIII fragment
bearing the vspC gene was determined. Within the sequenced
fragment a single open reading frame (ORF) containing 1,101 nt,
starting with an ATG initiation codon and terminating at a TAA stop
codon, was identified. More than 80% of the VspC molecule was composed of reiterated sequences extending from the N terminus to the C terminus
of the VspC protein. Four distinct internal regions of repetitive
sequences as tandem in-frame blocks were identified. Analysis of the
VspC deduced amino acid sequence revealed a remarkable homology to the
VspA lipoprotein (Fig. 2). The only
differences between VspC and VspA were 24 additional amino acid
residues and six amino acid substitutions in the VspC N-terminal region
and a deletion of one of the RA4 repetitive units within
the C terminus of the VspC molecule (Fig. 2).

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 2.
Alignment of the deduced amino acid sequences of VspA,
VspC, and VspO. Identical amino acid residues are shown by shaded
boxes. The solid lines under amino acid sequences within the N-terminal
region represent residues that are missing in VspA but are present in
VspO and VspC. Six solid squares below amino acid residues indicate
amino acid substitutions found within the N-terminal region of VspA.
Four distinct in-frame repetitive amino acid sequence domains within
the Vsp molecules are indicated within parentheses and labeled
RA1, RA2, RA3, and RA4.
An arrow shows the end of the region which exhibits 100% homology
between VspO and VspC and the beginning of the region displaying 100%
homology between VspC and VspA. Positions of the nt-2 oligonucleotide
and of the conserved Vsp lipoprotein signal peptide are shown by
labeled broken lines.
|
|
The next step was to determine the location of vspC in the
genome of the VspC clonal variant. The vsp locus from the
VspC isolate was cloned, sequenced, and compared to its counterpart of
the VspA isolate. Comparison of the two vsp loci revealed
two important findings. First, in the VspC isolate, vspC was
situated upstream of vspF and downstream of vspE
(Fig. 3B). In other words, the
vspC gene has replaced the original vspA gene
present in the variant expressing the VspA protein (Fig. 3A). Second, a
3.4-kb genomic fragment, carrying the vspM gene, the
vspN gene, and part of the vspO structural gene,
that was positioned downstream of the vspL gene and upstream
of ORF-5 in the VspA clonal isolate (Fig. 3A) was missing from the
vsp locus of the VspC variant (Fig. 3B).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of the M. bovis vsp genomic loci
from the VspA clonal isolate expressing a 63-kDa VspA protein (A) and
from a VspC clonal isolate expressing a 75-kDa product (B). The
locations and orientations of the vsp genes in each locus
are shown by shaded and labeled arrows. Four non-vsp ORFs
(ORF-2 to ORF-5) are shown by open labeled arrows. Positions of
HindIII (H) restriction sites are marked. The highly
conserved vsp-upstream region is shown by hatched blocks.
Locations of a 1,456-bp HindIII fragment carrying the
vspA gene in the VspA isolate, of a 1,506-bp
HindIII fragment carrying the vspC gene in
the VspC isolate, and of a 3.4-kb fragment carrying vspM,
vspN, and part of the vspO gene of the VspA isolate
that is missing in the VspC isolate are indicated by brackets. The 5'
end of an 8.0-kb HindIII genomic fragment (Fig. 5A, lane
1) in the VspA isolate is marked. Locations of two sets of PCR primers
(P5-1/nt-2 and P5-1/Pk-1) as well as sizes of the resultant PCR
products (1.5 and 2.1 kb, respectively) are marked. (C) PCR
amplification of M. bovis isolates. PCR primers P5-1 and
Pk-1 were used to amplify the corresponding genomic regions of isolates
168 (VspC75) (lane 1), 166 (VspC79) (lane 2),
and 182 (VspC75) (lane 3) and of M. bovis type
strain PG45 (lane 4). PCR primers P5-1 and nt-2 were used to amplify
the corresponding genomic region of isolates 7 (VspA63)
(lane 5) and M. bovis PG45 (lane 6). Sizes of the PCR
products are indicated.
|
|
At this point, we examined whether the deletion of the three
vsp genes observed in the variant expressing the VspC
protein could be also found in other VspC variants as well as among
cells of the original culture of type strain PG45. Two additional VspC clonal isolates and the original culture of M. bovis PG45
were analyzed by PCR. Two primers, representing sequences complementary to the vspK gene and to ORF-5 (designated, Pk-1 and P5-1,
respectively [Fig. 3B]) were used in PCR to amplify the genomic
region between the two corresponding genes in which the deletion has
occurred. As a control, the P5-1 primer together with another primer
(designated nt-2), which represents sequences complementary to the
vspO gene, were used to amplify the genomic region between
the vspO gene and ORF-5, a region that is unique to the VspA
isolate and absent in the VspC isolate (Fig. 3A). A single PCR product
of 2.1 kb was detected in all three VspC clonal isolates (Fig. 3C,
lanes 1 to 3), while a single PCR product of 1.5 kb was detected in the
VspA isolate (Fig. 3C, lane 5). Importantly, the same PCR products were
also obtained when the two distinct sets of PCR primers were used to
amplified the genomic DNA from the original M. bovis PG45
culture (Fig. 3C, lanes 4 and 6, respectively), indicating the
existence of both populations within the original strain.
Intergenic recombination between vspA and
vspO generates a chimeric and functional gene,
vspC.
The findings that the variant expressing the
VspC product contains the vspC gene but not the
vspA gene and vice versa were consistent with our inability
to detect by Southern blot hybridization the vspC gene in
the genomes of variants expressing the VspA product (14)
and with the fact that coexpression of VspA and VspC products was not
observed in M. bovis. These findings raised the possibility that an intergenic recombination event might have occurred between the
vspA gene and other vspA-related sequences and
led to the generation of a new coding sequence, namely, the
vspC gene. We therefore compared the vspC
nucleotide sequence and its deduced peptide with all other known
vsp gene and protein sequences (14). Comparison
of the vspC gene with one member of the vsp gene
family, vspO, provided the first evidence for the occurrence
of such a recombination event. A region of 390 nt starting from the
initiation codon was 100% identical between vspC and
vspO. This region, which encodes the N-terminal 130 amino
acid residues of the two Vsp proteins (Fig. 2), included the 24 amino
acid residues that were missing from VspA as well as the six amino acid
differences between VspA and VspC (Fig. 2).
Additional data pointing to the occurrence of a recombination event
between vspA and vspO were obtained when the
nucleotide sequence of the vspC-upstream region was compared
with those of all known vsp genes (14). The
vsp-upstream region was recently shown to be highly
conserved among all vsp genes and to possess two cassettes.
Cassette 1, a 71-bp segment upstream of the ATG initiation codon,
exhibited 98% nucleic acid identity among all vsp genes;
cassette 2, about 160 bp, exhibited a more divergent sequence
(14). As shown in Fig. 4,
cassette 1 of the vspC was found to be 100% identical to
cassette 1 of the vspO and could be distinguished from that
of vspA by the presence of distinctive nucleotide signatures
(Fig. 4). Interestingly, however, cassette 2 of vspC showed
100% sequence identity to that of vspA and was clearly
different from that of vspO (Fig. 4).

View larger version (88K):
[in this window]
[in a new window]
|
FIG. 4.
Nucleotide sequence alignment of regions 5' of the
structural genes vspA, vspC, and vspO. Identical
nucleotides are highlighted by shaded boxes. An arrow at nt -71 indicates the end of the region displaying 100% homology between
vspO and vspC genes and the beginning of the
region of 100% homology between vspC and vspA.
This arrow also marks the junction between the two-vsp
upstream cassettes 1 and 2 (14). Solid rectangles below
nucleotides represent two nucleotide differences which are unique to
the vspA upstream region and served as vspA
fingerprints. The position of the cas-2 oligonucleotide, used as a
probe, is shown by a labeled broken line. Nucleotides representing a
putative ribosome binding site (SD) and the initiation codon ATG are
shown by brackets. A 34-bp sequence in which the 5' end of the
recombination event between vspA and vspO has
occurred is underlined.
|
|
Experimental evidence supporting the generation of the vspC
gene through an intergenic recombination event between vspA
and vspO was obtained by monitoring the presence and size of
the vspA- and vspO-bearing fragments in the
genomes of the two clonal variants described in Fig. 1A and 3. Two
synthetic oligonucleotides were used in Southern blot hybridization
with HindIII-digested genomic DNAs of the two clonal
variants. The first oligonucleotide, designated nt-2, was complementary
to the N-terminus-encoding region of the vspO gene. This
sequence was also found in the N-terminal region of the vspC
gene but not in the vspA gene (Fig. 2). Thus, this probe can
identify the vspO N-terminus-encoding region as well as the
corresponding region in the vspC gene. The second
oligonucleotide, designated cas-2, was complementary to vspA
cassette 2, which was also found in the chimeric vspC gene
(Fig. 4). This probe can monitor the corresponding genomic fragment
carrying vspA cassette 2 in both clonal isolates.
As expected, an approximately 8-kb HindIII genomic
fragment carrying the vspO gene (14) was
identified by the nt-2 oligonucleotide probe in the VspA isolate (Fig.
5A, lane 1; Fig. 3). However, in the VspC
clonal isolate the vspO N-terminus-encoding region was
identified on a 1.5-kb HindIII fragment shown in this
study to carry the complete vspC gene (Fig. 5A, lane 2; Fig.
3). In parallel, by using the cas-2 probe, vspA cassette 2, present on a 1,456 bp HindIII fragment carrying the
vspA gene in the VspA isolate (Fig. 5B, lane 1; Fig. 3), was
identified on the 1,506-bp HindIII fragment carrying the
vspC gene in the VspC isolate (Fig. 5B, lane 2; Fig. 3).

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 5.
Monitoring the recombination event between the
vspA and vspO genes. For Southern blot
hybridization of the two clonal isolates depicted in Fig. 1A and 3,
genomic DNAs were digested with HindIII restriction
enzyme and probed with the nt-2 oligonucleotide probe, which represents
sequences complementary to the N-terminus-encoding region common to
vspC and vspO (A), with vspA cassette
2-specific probe cas-2 (B), or with vspO-specific probe ro-2
(C). HindIII genomic fragments bearing the
vspO or vspC gene are marked by labeled arrows.
|
|
The acquisition of the N-terminus-encoding region of the
vspO gene by the corresponding region of the vspC
gene was also examined at the protein level using MAb 2A8, previously
shown to recognize VspC but not VspA (Fig.
6A) (4). As was shown in
this study, the only differences between the VspA and VspC amino acid
sequences were confined to the N-terminal region (Fig. 2), which
presumably contains the epitope recognized by MAb 2A8. Since the
vspC N-terminus-encoding region was completely acquired from
the vspO gene, we expressed in E. coli the
recombinant vspO gene from the VspA isolate as well as the
recombinant vspC gene and examined their reactivities with
MAb 2A8 by Western blot analysis. Both recombinant VspC protein and
recombinant VspO protein (Fig. 6B, lanes 1 and 2, respectively) were
clearly recognized by MAb 2A8, indicating the acquisition of the
N-terminus-encoding region of the vspO gene into the hybrid vspC gene. The formation of the chimeric vspC
gene through a recombination event occurring between vspA
and vspO is schematically demonstrated in Fig.
7. A 34-bp sequence within the conserved
cassette 1 upstream of the vspA and vspO genes
(designated A1 and O1, respectively) was
identified as the putative 5' site of the recombination event (Fig. 4
and 7). As a result, vspA cassette 2 (A2) was
fused to the vspO cassette 1 (O1), generating
the A2-O1-vspC-upstream region. The
3' end of the recombination event was localized at the last repeat
within the RA1 repetitive domain, which is common to the vspA and vspO genes (Fig. 7). The identification
of the exact 3' end within the RA1 repetitive domain was
possible due to the presence of a few nucleotide substitutions that
served as distinctive fingerprints for the involved genes (Fig. 7)
(14).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
(A) Western blot analysis of the VspA and VspC clonal
isolates. Total cell proteins from the VspC (lane 2) and VspA (lane 1)
isolates were immunoblotted with MAb 2A8 (27). The
authentic VspC 75-kDa protein band is indicated by an arrow. (B)
Expression in E. coli of recombinant vspC and
vspO genes. E. coli cells expressing, under
selective control of the T7 promoter, the recombinant plasmid
pKC75 carrying the vspC gene (lane 1) or the
recombinant plasmid pKO35 carrying the vspO gene
were separated by SDS-PAGE and immunoblotted with MAb 2A8. The
recombinant VspC and the VspO products (75 and 35 kDa, respectively)
are marked by labeled arrows. Notably, the size of the recombinant VspO
product expressed in E. coli does not represent the complete
vspO coding sequence due to the presence of two UGA residues
at the C terminus (which encode the amino acid tryptophan in
mycoplasmas). No UGA codons were found within the vspC
gene.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 7.
Schematic representation of the generation of the
vspC gene by an intrachromosomal recombination between
vspA and vspO. Structures of vspA,
vspO, and vspC are presented schematically by aligned
rectangles. Each vsp gene is flanked 5' by a highly
conserved noncoding region composed of two cassettes, labeled 1 and 2 with the letter of the corresponding gene. A block labeled signal
represents a highly homologous sequence encoding a lipoprotein signal
peptide. In-frame reiterated coding sequences extending from the N
terminus to the C terminus of the Vsp proteins and encoding periodic
amino acid sequences are shown by differently hatched blocks.
Distinctive repetitive domains within each Vsp are labeled with R and
the letter of the corresponding vsp gene. Repetitive units
present in more than one Vsp molecule are similarly hatched. Numbers on
the right indicate the length of each Vsp polypeptide chain. Small
black squares denote distinctive nucleotide changes which exist in
vspO and vspC but not in vspA, while
solid dots represent a distinctive signature present in vspA
and vspC but not in vspO. A shaded block
represents a 66-bp sequence present in vspO and
vspC but absent in vspA. Small labeled arrows
mark the locations of the cas-2, ro-2, nt-2, and ra-4 oligonucleotides
used as probes in Southern blot experiments. The position of a 34-bp
sequence, within cassette 1 of the vspA, vspO, and
vspC genes, which served as the putative 5'-end site for the
recombination event is marked by a broken arrow and brackets. The 3'
end of the recombination event, which is located within the repetitive
domains RA1 and RO1 of the vspA and
the vspO genes, is marked by a broken line.
|
|
The vspC gene is therefore an embodiment of the following
domains: an N-terminus-encoding region linked to an upstream region (cassette 1) provided by the vspO gene; and a
C-terminus-encoding region and a more distal upstream region (cassette
2) acquired from the vspA gene.
Generation of the chimeric vspC gene is a nonreciprocal
event.
The recombination event between vspA and
vspO has led on one hand to the generation of the chimeric
and functional gene vspC, which was shown to undergo
independent high-frequency phase variation and to be highly immunogenic
(3; Y. Ron, I. Lysnyansky, and D. Yogev, unpublished
results), but on the other hand to a loss of genetic material
containing three vsp genes (vspM, vspN, and vspO). This was evident when the vsp locus of the
VspC variant was cloned and sequenced (Fig. 3). Thus, the generation of
the vspC gene appears to be a nonreciprocal event, and the
reciprocal product, which should consist of the N-terminus-encoding
region of the vspA gene and of the C-terminus-encoding
region of the vspO gene, was not generated during this event
(Fig. 3 and 7). To examine the possibility that a reciprocal product
might still be present elsewhere in the chromosome of the VspC isolate,
three synthetic oligonucleotides representing unique sequences of the vspM, vspN, and vspO structural genes
(14) (designated rm-2, 49n, ro-2, respectively) were used
as probes in Southern blot hybridization with
HindIII-digested genomic DNAs of the two variants depicted in Fig. 1A and 3. An example of such hybridization using the
vspO-specific oligonucleotide (ro-2) probe is shown in Fig. 5C. The vspO probe identified, as expected, the 8.0-kb
HindIII genomic fragment carrying the vspO
gene in the genome of the variant expressing the VspA product (Fig. 5C,
lane 1; Fig. 3). However, no vspO-related genomic fragments
were observed in the genome of the VspC variant (Fig. 5C, lane 2).
Similarly, no vspM- or vspN-related genomic
fragments were observed in the genome of the VspC variant by using the
vspM- or vspN-specific probe (data not shown).
Thus, the recombination event between the vspA and the
vspO genes which led to the generation of the
vspC gene did not produce a reciprocal product but caused a
deletion within the vsp genomic locus.
 |
DISCUSSION |
In previous studies, systematic analysis of several isogenic
clonal lineages of M. bovis type strain PG45 allowed the
isolation of clonal variants exhibiting discrete Vsp phenotypes
(3, 13). These phenotypes included single as well as
combinatorial expression of three distinct major immunogens: VspA,
VspB, and VspC. Although each Vsp was shown to undergo independent
high-frequency phase variation, an isolate coexpressing both VspA and
VspC lipoproteins was not observed. Moreover, genetic analysis of an
isolate coexpressing both VspA and VspB failed to detect the
vspC gene within the vsp locus or elsewhere in
the M. bovis chromosome (14).
The present study revealed that vspC is a chimeric gene
generated by an intragenic recombination between two closely related vsp genes: the formerly expressed vspA gene and
the vspO gene, both positioned within the vsp
locus at a distance of 13.4 kb (14). Examination of the 5'
and the 3' ends of the rearranged region revealed that vsp
homologous sequences were utilized. A 34-bp sequence within the highly
conserved cassette 1 common to all vsp-upstream regions
(14) was identified as the potential 5' site for the
recombination event (Fig. 4 and 7), while identical reiterated
sequences (RA1) within the coding regions of
vspA and vspO served as potential recombination
sites at the 3' end (Fig. 7). It should be noted that the 34-bp
sequence within the conserved cassette 1 was also identified as a
potential site for site-specific DNA inversion events that were found
to mediate VspA and VspC phase variation (I. Lysnyansky and D. Yogev,
unpublished results; Y. Ron, I. Lysnyansky, and D. Yogev, unpublished
results). Recombination events generating chimeric vsp genes
may be initiated by a cleavage within the 34-bp sequence, while the
downstream recombination might then occur at any site bearing
sufficient sequence similarity, including sites within the
vsp genes themselves, as was shown in this study for the
formation of the vspC gene.
As to the deletion of a genomic fragment during the generation of the
chimeric vspC gene, in Borrelia burgdorferi,
deletion of gene sequences during the formation of chimeric gene
fusions by intramolecular recombination between two osp
genes was demonstrated (26). A deletion of DNA sequences
was also observed in Borrelia hermsii during activation of
the vmp pseudogene (24). The vspA and vspO genes are localized within the vsp locus
in opposite orientations. Their opposite genomic orientations argue
against a looping-out configuration as a mechanism that would generate a deletion, as was shown for example for the ospA and
ospB genes of B. burgdorferi (26),
and suggest a nonconservative recombination by as yet an unknown
mechanism. Collectively, the presence of highly homologous sequences 5'
to all vsp genes and the recurrence of similar reiterated
sequences within the coding region of several vsp genes
(14) suggest that these regions might serve as potential sites for intrachromosomal recombination events (19, 32)
that could occur between other vsp genes. Therefore, a large
repertoire of chimeric vsp genes can potentially be
generated, affecting the vsp genomic and antigenic repertoire.
Generation and expression of chimeric vsp genes might
provide an important element of genetic variation and additional source of antigenic diversification within the mycoplasma population, which of
course increases the microorganism's flexibility to deal with the
immunologic problem posed by the host. However, it also raises a
question regarding the benefit of the final outcome, at least in the
case of the vspC gene. Experimental evidence obtained in
this study indicated that the generation of the vspC gene by intrachromosomal recombination between two vsp homologs
(vspA and vspO) led to irreversible loss of
genetic material within the vsp locus. First, sequence
analysis of the vsp locus from the VspC variant has shown
that three vsp genes are missing in that isolate (Fig. 3).
Second, Southern blot analysis using vsp-specific oligonucleotides could not detect within the vsp locus or
elsewhere in the chromosome of the VspC variant a reciprocal product
containing the vspA N-terminus-encoding region and the
vspO C terminus (Fig. 5C). Third, PCR analysis of the
original M. bovis type strain PG45 has clearly shown the
presence of cells within the population harboring a deletion of three
vsp genes in the vsp locus along with cells
carrying the complete vsp locus (Fig. 3C). Analysis of two
additional VspC clonal isolates expressing VspC products of different
sizes has also shown the presence of a deleted vsp locus.
Why would an organism with limited genetic material undergo a terminal
event leading to a loss of coding sequences? One possibility is that
during growth in culture the vsp locus is not under
selective pressure to maintain a particular gene configuration. The
lack of selective pressure on one hand, and the presence of highly homologous sequences, within the upstream vsp regions as
well as sites within the vsp genes themselves, on the other
hand, allow the occurrence of apparently a wide range of recombination
events. Some of these in vitro rearrangement events may generate,
within the entire population, distinct cells harboring chimeric
vsp genes and/or deletions within the vsp locus.
In culture, in the absence of a selective pressure these variants
survive and can be isolated as was shown for the VspC variant. However,
after inoculation into the animal host, when selective pressure is
restored, natural selection of antigenic phenotypes needed for adapting
the host environment or evading its defense mechanisms is likely to
take place in vivo. Subpopulations of M. bovis cells that
possess particular vsp gene configurations and express the
appropriate antigenic presentations will survive, while other
phenotypes will die. While the frequency of appearance of the VspC
phenotype during in vitro growth was measured to be 10
3
to 10
5 per cell per generation (3, 13), the
frequency of occurrence of the chimeric vspC gene in vivo in
the bovine is unknown. It is therefore possible that the VspA and the
deleted VspC phenotypes confer different selective advantages during in
vitro growth and passage and thus do not reflect the frequency or the
precise nature of that event in vivo. Nevertheless, generation of
chimeric vsp genes may still be part of a survival strategy
of the mycoplasma and underscores the efficient way mycoplasmas may
utilize their limited genetic material when confronted with the host environment.
Bacterial pathogens utilize a wide diversity of molecular mechanisms to
vary the antigenic characteristics of their cell surface (1, 6,
21, 23, 25, 30, 34, 36, 38). In many, the presence of a family
of related genes favors the occurrence of DNA rearrangements mediating
on/off switching mechanisms and operating at high frequency (5,
8, 16, 23, 30). The possibility of creating functional chimeric
gene fusions among homologs within a gene family is another important
consequence of DNA rearrangements affecting the antigenic presentation
of the microorganism (18). For example, recombination
between sapA homologs of Campylobacter fetus
leads to expression of a divergent S-layer protein (7, 9,
36). In B. burgdorferi (26) or B. hermsii (11), an intragenic recombination between
osp or vmp genes, respectively, generates a
chimeric gene fusion and is considered an additional mechanism for
antigenic variation.
The high rate of DNA rearrangements observed in the chromosome of
M. bovis (13), as well as in M. pulmonis (5), places the minute mycoplasma chromosome
as one of the most dynamic and variable genomes known. The
vsp gene family of M. bovis represents a complex
system in which three distinct ways to achieve surface diversity are
independently utilized: (i) high-frequency on/off switching of
individual Vsps, (ii) generation of numerous Vsp size variants, and
(iii) formation of chimeric vsp genes encoding variable
surface lipoproteins. Although the frequency of occurrence of each
process in vivo is not known, the combination of these molecular traits
might provide an important element of genetic variation within the
mycoplasma population contributing to rapid evolution of the variable
antigen gene repertoire.
 |
ACKNOWLEDGMENTS |
This study was supported in part by the German-Israeli Foundation
for Scientific Research and Development, by research grant IS-3126-99
from The United States-Israel Binational Agricultural Research and
Development Fund, and by the Israel Academy of Sciences and Humanities Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Membrane and Ultrastructure Research, The Hebrew University-Hadassah Medical School, P.O. Box 12272, Jerusalem 91120, Israel. Phone: 972-2-6758176. Fax: 972-2-6784010. E-mail:
yogev{at}cc.huji.ac.il.
Editor:
V. J. DiRita
 |
REFERENCES |
| 1.
|
Barbour, A. G.,
N. Burman,
C. J. Carter,
T. Kitten, and S. Bergstrom.
1991.
Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition.
Mol. Microbiol.
5:489-493[CrossRef][Medline].
|
| 2.
|
Baseggio, N.,
M. D. Glew,
P. F. Markham,
K. G. Whithear, and G. F. Browning.
1996.
Size and genomic location of the pMGA multigene family of Mycoplasma gallisepticum.
Microbiology
142:1429-1435[Abstract].
|
| 3.
|
Behrens, A.,
M. Heller,
H. Kirchhoff,
D. Yogev, and R. Rosengarten.
1994.
A family of phase- and size-variant membrane surface lipoprotein antigens (Vsps) of Mycoplasma bovis.
Infect. Immun.
62:5075-5084[Abstract/Free Full Text].
|
| 4.
|
Beier, T.,
H. Hotzel,
I. Lysnyansky,
C. Grajetzki,
M. Heller,
B. Rabeling,
D. Yogev, and K. Sachse.
1998.
Intraspecies polymorphism of vsp genes and expression profiles of variable surface protein antigens (Vsps) in field isolates of Mycoplasma bovis.
Vet. Microbiol.
63:189-203[CrossRef][Medline].
|
| 5.
|
Bhugra, B.,
L. L. Voelker,
N. Zou,
H. Yu, and K. Dybvig.
1995.
Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions.
Mol. Microbiol.
18:703-714[CrossRef][Medline].
|
| 6.
|
Borst, P., and D. R. Greaves.
1987.
Programmed gene rearrangements altering gene expression.
Science
235:658-667[Abstract/Free Full Text].
|
| 7.
|
Dworkin, J., and M. J. Blaser.
1997.
Molecular mechanisms of Campylobacter fetus surface layer protein expression.
Mol. Microbiol.
26:433-440[CrossRef][Medline].
|
| 8.
|
Dybvig, K.
1993.
DNA rearrangements and phenotypic switching in prokaryotes.
Mol. Microbiol.
10:465-471[CrossRef][Medline].
|
| 9.
|
Garcia, M. M.,
C. L. Lutze-Wallace,
A. S. Denes,
M. D. Eaglesome,
E. Holst, and M. J. Blaser.
1995.
Protein shift and antigenic variation in the S-layer of Campylobacter fetus subsp. venerealis during bovine infection accompanied by genomic rearrangement of sapA homologs.
J. Bacteriol.
177:1976-1980[Abstract/Free Full Text].
|
| 10.
|
Jasper, D. E.
1982.
The role of Mycoplasma in bovine mastitis.
J. Am. Vet. Med. Assoc.
181:158-162[Medline].
|
| 11.
|
Kitten, T.,
A. V. Barrera, and A. G. Barbour.
1993.
Intragenic recombination and a chimeric outer membrane protein in the relapsing fever agent Borrelia hermsii.
J. Bacteriol.
175:2516-2522[Abstract/Free Full Text].
|
| 12.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 13.
|
Lysnyansky, I.,
R. Rosengarten, and D. Yogev.
1996.
Phenotypic switching of variable surface lipoproteins in Mycoplasma bovis involves high-frequency chromosomal rearrangements.
J. Bacteriol.
178:5395-5401[Abstract/Free Full Text].
|
| 14.
|
Lysnyansky, I.,
K. Sachse,
R. Rosenbusch,
S. Levisohn, and D. Yogev.
1999.
The vsp locus of Mycoplasma bovis: gene organization and structural features.
J. Bacteriol.
181:5734-5741[Abstract/Free Full Text].
|
| 15.
|
Marmur, J.
1961.
A procedure for the isolation of deoxyribonucleic acid from microorganisms.
J. Mol. Biol.
3:208-218.
|
| 16.
|
Meyer, T. F.,
C. P. Gibbs, and R. Haas.
1990.
Variation and control of protein expression in Neisseria.
Annu. Rev. Microbiol.
44:451-477[CrossRef][Medline].
|
| 17.
|
Noormohammadi, A. H.,
P. F. Markham,
A. Kanci,
K. G. Whithear, and G. F. Browning.
2000.
A novel mechanism for control of antigenic variation in the haemagglutinin gene family of Mycoplasma synoviae.
Mol. Microbiol.
35:911-923[CrossRef][Medline].
|
| 18.
|
Pays, E.
1989.
Pseudogenes, chimaeric genes and the timing of antigen variation in African trypanosomes.
Trends Genet.
5:389-391[CrossRef][Medline].
|
| 19.
|
Petes, T. D., and C. W. Hill.
1988.
Recombination between repeated genes in microorganisms.
Annu. Rev. Genet.
22:147-168[CrossRef][Medline].
|
| 20.
|
Pfützner, H., and K. Sachse.
1996.
Mycoplasma bovis as an agent of mastitis, pneumonia, arthritis and genital disorders in cattle.
Rev. Sci. Tech. Off. Int. Epizoot.
15:1477-1494.
|
| 21.
|
Plasterk, R. H. A.,
M. I. Simon, and A. G. Barbour.
1985.
Transposition of structural genes to an expression sequence on a linear plasmid causes antigenic variation in the bacterium Borrelia hermsii.
Nature
318:257-263[CrossRef][Medline].
|
| 22.
|
Rainey, P. B.,
E. R. Moxon, and I. P. Thompson.
1993.
Intraclonal polymorphism in bacteria.
Adv. Microb. Ecol.
13:263-300.
|
| 23.
|
Razin, S.,
D. Yogev, and Y. Naot.
1998.
Molecular biology and pathogenicity of mycoplasmas.
Microbiol. Mol. Biol. Rev.
62:1094-1156[Abstract/Free Full Text].
|
| 24.
|
Restrepo, B. I.,
C. J. Carter, and A. G. Barbour.
1994.
Activation of a vmp pseudogene in Borrelia hermsii: an alternative mechanism of antigenic variation during relapsing fever.
Mol. Microbiol.
13:287-299[Medline].
|
| 25.
|
Robertson, B. D., and T. F. Meyer.
1992.
Antigenic variation in bacterial pathogens.
Symp. Soc. Gen. Microbiol.
49:61-73.
|
| 26.
|
Rosa, P. A.,
T. Schwan, and D. Hogan.
1992.
Recombination between genes encoding major outer surface proteins A and B of Borrelia burgdorferi.
Mol. Microbiol.
6:3031-3040[CrossRef][Medline].
|
| 27.
|
Sachse, K.,
J. H. Helbig,
I. Lysnaynsky,
C. Grajetzki,
W. Muller,
E. Jacobs, and D. Yogev.
2000.
Epitope mapping of immunogenic and adhesive structures in repetitive domains of Mycoplasma bovis variable surface lipoproteins.
Infect. Immun.
68:680-687[Abstract/Free Full Text].
|
| 28.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 29.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 30.
|
Seifert, H. S., and M. So.
1988.
Genetic mechanisms of bacterial antigenic variation.
Microbiol. Rev.
52:327-336[Free Full Text].
|
| 31.
|
Simecka, J. W.,
J. K. Davis,
M. K. Davidson,
S. E. Ross,
C. T. K.-H. Stadtländer, and G. H. Cassell.
1992.
Mycoplasma diseases of animals, p. 391-416.
In
J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
|
| 32.
|
Smith, G. R.
1994.
Hotspots of homologous recombination.
Experientia
50:234-241[CrossRef][Medline].
|
| 33.
|
Tabor, S., and C. C. Richardson.
1985.
A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.
Proc. Natl. Acad. Sci. USA
82:1074-1078[Abstract/Free Full Text].
|
| 34.
|
Thon, G.,
T. Baltz, and H. Eisen.
1989.
Antigenic diversity by the recombination of pseudogenes.
Genes Dev.
3:1247-1254[Abstract/Free Full Text].
|
| 35.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 36.
|
Tummuru, M. K. R., and M. J. Blaser.
1993.
Rearrangement of sapA homologs with conserved and variable regions in Campylobacter fetus.
Proc. Natl. Acad. Sci. USA
90:7265-7269[Abstract/Free Full Text].
|
| 37.
|
Wise, K. S.,
D. Yogev, and R. Rosengarten.
1992.
Antigenic variation, p. 473-489.
In
J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
|
| 38.
|
Yogev, D.,
R. Rosengarten,
R. Watson-McKown, and K. S. Wise.
1991.
Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5' regulatory sequences.
EMBO J.
10:4069-4079[Medline].
|
Infection and Immunity, June 2001, p. 3703-3712, Vol. 69, No. 6
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.6.3703-3712.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Degrange, S., Renaudin, H., Charron, A., Bebear, C., Bebear, C. M.
(2008). Tetracycline Resistance in Ureaplasma spp. and Mycoplasma hominis: Prevalence in Bordeaux, France, from 1999 to 2002 and Description of Two tet(M)-Positive Isolates of M. hominis Susceptible to Tetracyclines. Antimicrob. Agents Chemother.
52: 742-744
[Abstract]
[Full Text]
-
Madsen, M. L., Oneal, M. J., Gardner, S. W., Strait, E. L., Nettleton, D., Thacker, E. L., Minion, F. C.
(2007). Array-Based Genomic Comparative Hybridization Analysis of Field Strains of Mycoplasma hyopneumoniae. J. Bacteriol.
189: 7977-7982
[Abstract]
[Full Text]
-
Burgos, R., Pich, O. Q., Ferrer-Navarro, M., Baseman, J. B., Querol, E., Pinol, J.
(2006). Mycoplasma genitalium P140 and P110 Cytadhesins Are Reciprocally Stabilized and Required for Cell Adhesion and Terminal-Organelle Development. J. Bacteriol.
188: 8627-8637
[Abstract]
[Full Text]
-
Gaurivaud, P., Persson, A., Grand, D. L., Westberg, J., Solsona, M., Johansson, K.-E., Poumarat, F.
(2004). Variability of a glucose phosphotransferase system permease in Mycoplasma mycoides subsp. mycoides Small Colony. Microbiology
150: 4009-4022
[Abstract]
[Full Text]
-
McAuliffe, L., Kokotovic, B., Ayling, R. D., Nicholas, R. A. J.
(2004). Molecular Epidemiological Analysis of Mycoplasma bovis Isolates from the United Kingdom Shows Two Genetically Distinct Clusters. J. Clin. Microbiol.
42: 4556-4565
[Abstract]
[Full Text]
-
Flitman-Tene, R., Mudahi-Orenstein, S., Levisohn, S., Yogev, D.
(2003). Variable Lipoprotein Genes of Mycoplasma agalactiae Are Activated In Vivo by Promoter Addition via Site-Specific DNA Inversions. Infect. Immun.
71: 3821-3830
[Abstract]
[Full Text]
-
Glew, M. D., Marenda, M., Rosengarten, R., Citti, C.
(2002). Surface Diversity in Mycoplasma agalactiae Is Driven by Site-Specific DNA Inversions within the vpma Multigene Locus. J. Bacteriol.
184: 5987-5998
[Abstract]
[Full Text]
-
Nussbaum, S., Lysnyansky, I., Sachse, K., Levisohn, S., Yogev, D.
(2002). Extended Repertoire of Genes Encoding Variable Surface Lipoproteins in Mycoplasma bovis Strains. Infect. Immun.
70: 2220-2225
[Abstract]
[Full Text]
-
Lysnyansky, I., Ron, Y., Yogev, D.
(2001). Juxtaposition of an Active Promoter to vsp Genes via Site-Specific DNA Inversions Generates Antigenic Variation in Mycoplasma bovis. J. Bacteriol.
183: 5698-5708
[Abstract]
[Full Text]